Delivery Order SPE2DP20D0002-SPE2DP24F2005
Award Date 1/25/24
Potential Completion Date 1/30/24
Potential Value $318K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024 and does not utilize a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 A vaccine. The contract has a completion date of January 30, 2024 and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. has been awarded numerous prime federal contracts to supply critical pharmaceutical products to the Department of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $282,353.76 contract has an April 27, 2021 completion date and does not have a set-aside designation. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that has supplied various pharmaceutical products, including vaccines, antiviral medications, respiratory...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,270,437.84 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc. to provide Adenovirus Type 4 vaccines. Teva is a large, foreign-owned pharmaceutical manufacturer that has fulfilled numerous federal contracts for critical medical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs for agencies such as the Department of Veterans Affairs (VA) and Department of...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The $271,494.00 award has a completion date of June 23, 2020 and was issued on June 17, 2020. Teva is an experienced government contractor, having received numerous delivery orders from DLA Troop Support Medical to supply adenovirus vaccines in support of military immunization...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $158,804.73 contract, which has no set-aside designation, is for the supply of Adenovirus Type 4 A vaccine with a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. has been awarded multiple federal contracts and delivery orders from agencies like the Department of Veterans...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. This delivery order is not set aside and is part of a larger $5.7 million indefinite-delivery contract (IDC) that establishes Teva as the national prime vendor to supply Levalbuterol HCL solution to the Department of Defense (DOD), Department of...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. The $146,823.93 order is not set aside and has a completion date of July 26, 2022. Teva has previously received numerous delivery orders from the Defense Logistics Agency to supply adenovirus vaccines and other pharmaceutical products such as albuterol inhalers to federal...
- The Defense Logistics Agency Troop Support Medical awarded a $282,353.76 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This award is not associated with a set-aside contract. Teva Pharmaceuticals has a history of providing pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal customers such as...